Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Migraine

Free Subscription Articles published in Cephalalgia Retrieve available abstracts of 248 articles: HTML format Text format

Single Articles

July 2019
1. KUAN AS, Chen SP, Wang YF, Fuh JL, et al
   Risk factors and psychological impact of syncope in migraine patients.
   Cephalalgia. 2019 Jul 15:333102419865253. doi: 10.1177/0333102419865253.
   PubMed     Text format     Abstract available
   
   
   
2. GHANIZADA H, Al-Mahdi Al-Karagholi M, Arngrim N, Olesen J, et al
   PACAP27 induces migraine-like attacks in migraine patients.
   Cephalalgia. 2019 Jul 12:333102419864507. doi: 10.1177/0333102419864507.
   PubMed     Text format     Abstract available
   
   
   
3. CHRISTENSEN SL, Petersen S, Kristensen DM, Olesen J, et al
   Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain.
   Cephalalgia. 2019 Jul 9:333102419861726. doi: 10.1177/0333102419861726.
   PubMed     Text format     Abstract available
   
   
   
4. DOTY EG, Krege JH, Jin L, Raskin J, et al
   Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine.
   Cephalalgia. 2019 Jul 3:333102419859313. doi: 10.1177/0333102419859313.
   PubMed     Text format     Abstract available
   
   
   
5. FARRIS SG, Thomas JG, Abrantes AM, Lipton RB, et al
   Anxiety sensitivity and intentional avoidance of physical activity in women with probable migraine.
   Cephalalgia. 2019 Jul 1:333102419861712. doi: 10.1177/0333102419861712.
   PubMed     Text format     Abstract available
   
   
   
6. MAGNI G, Boccazzi M, Bodini A, Abbracchio MP, et al
   Basal astrocyte and microglia activation in the central nervous system of Familial Hemiplegic Migraine Type I mice.
   Cephalalgia. 2019 Jul 1:333102419861710. doi: 10.1177/0333102419861710.
   PubMed     Text format     Abstract available
   
   
   June 2019
7. DODICK DW, Lipton RB, Silberstein S, Goadsby PJ, et al
   Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial.
   Cephalalgia. 2019 Jun 24:333102419858355. doi: 10.1177/0333102419858355.
   PubMed     Text format     Abstract available
   
   
   
8. STEFANO MD, Pucci E, Miceli E, Pagani E, et al
   Prevalence and pathophysiology of post-prandial migraine in patients with functional dyspepsia.
   Cephalalgia. 2019 Jun 15:333102419857596. doi: 10.1177/0333102419857596.
   PubMed     Text format     Abstract available
   
   
   
9. HOFFMAN V, Xue F, Ezzy SM, Yusuf A, et al
   Risk of cardiovascular and cerebrovascular events and mortality in patients with migraine receiving prophylactic treatments: An observational cohort study.
   Cephalalgia. 2019 Jun 13:333102419856630. doi: 10.1177/0333102419856630.
   PubMed     Text format     Abstract available
   
   
   
10. KREGE JH, Rizzoli PB, Liffick E, Doty EG, et al
    Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN.
    Cephalalgia. 2019 Jun 5:333102419855080. doi: 10.1177/0333102419855080.
    PubMed     Text format     Abstract available
    
    
    
11. OGUZ AKARSU E, Baykan B, Ertas M, Zarifoglu M, et al
    The persistence versus interchangeability of migraine and tension-type headaches in a 5-year population-based validated survey.
    Cephalalgia. 2019 Jun 4:333102419852359. doi: 10.1177/0333102419852359.
    PubMed     Text format     Abstract available
    
    
    
12. MONTAZERLOTFELAHI H, Amanat M, Tavasoli AR, Agah E, et al
    Levetiracetam for prophylactic treatment of pediatric migraine: A randomized double-blind placebo-controlled trial.
    Cephalalgia. 2019 Jun 1:333102419851814. doi: 10.1177/0333102419851814.
    PubMed     Text format     Abstract available
    
    
    
13. MEYERS JL, Davis KL, Lenz RA, Sakai F, et al
    Treatment patterns and characteristics of patients with migraine in Japan: A retrospective analysis of health insurance claims data.
    Cephalalgia. 2019 Jun 1:333102419851855. doi: 10.1177/0333102419851855.
    PubMed     Text format     Abstract available
    
    
    May 2019
14. ASHINA M, Goadsby PJ, Reuter U, Silberstein S, et al
    Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine.
    Cephalalgia. 2019 May 30:333102419854082. doi: 10.1177/0333102419854082.
    PubMed     Text format     Abstract available
    
    
    
15. BRAGATTO MM, Bevilaqua-Grossi D, Benatto MT, Lodovichi SS, et al
    Is the presence of neck pain associated with more severe clinical presentation in patients with migraine? A cross-sectional study.
    Cephalalgia. 2019 May 27:333102419854061. doi: 10.1177/0333102419854061.
    PubMed     Text format     Abstract available
    
    
    
16. 
    Corrigendum: CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
    Cephalalgia. 2019 May 24:333102419854298. doi: 10.1177/0333102419854298.
    PubMed     Text format    
    
    
    
17. DODICK DW, Silberstein SD, Lipton RB, DeGryse RE, et al
    Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data.
    Cephalalgia. 2019 May 21:333102418825382. doi: 10.1177/0333102418825382.
    PubMed     Text format     Abstract available
    
    
    
18. KOGELMAN LJ, Falkenberg K, Halldorsson GH, Poulsen LU, et al
    Comparing migraine with and without aura to healthy controls using RNA sequencing.
    Cephalalgia. 2019 May 19:333102419851812. doi: 10.1177/0333102419851812.
    PubMed     Text format     Abstract available
    
    
    
19. RUFF DD, Ford JH, Tockhorn-Heidenreich A, Sexson M, et al
    Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure.
    Cephalalgia. 2019 May 19:333102419847957. doi: 10.1177/0333102419847957.
    PubMed     Text format     Abstract available
    
    
    
20. HAANES KA, Labastida-Ramirez A, Blixt FW, Rubio-Beltran E, et al
    Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models.
    Cephalalgia. 2019 May 19:333102419851810. doi: 10.1177/0333102419851810.
    PubMed     Text format     Abstract available
    
    
    
21. KHAN S, Amin FM, Fliedner FP, Christensen CE, et al
    Investigating macrophage-mediated inflammation in migraine using ultrasmall superparamagnetic iron oxide-enhanced 3T magnetic resonance imaging.
    Cephalalgia. 2019 May 19:333102419848122. doi: 10.1177/0333102419848122.
    PubMed     Text format     Abstract available
    
    
    
22. TANG W, Zhang M, Qiu E, Kong S, et al
    A Chinese family with familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2.
    Cephalalgia. 2019 May 3:333102419847738. doi: 10.1177/0333102419847738.
    PubMed     Text format     Abstract available
    
    
    
23. DUMKRIEGER G, Chong CD, Ross K, Berisha V, et al
    Static and dynamic functional connectivity differences between migraine and persistent post-traumatic headache: A resting-state magnetic resonance imaging study.
    Cephalalgia. 2019 May 1:333102419847728. doi: 10.1177/0333102419847728.
    PubMed     Text format     Abstract available
    
    
    
24. KAISER EA, Igdalova A, Aguirre GK, Cucchiara B, et al
    A web-based, branching logic questionnaire for the automated classification of migraine.
    Cephalalgia. 2019 May 1:333102419847749. doi: 10.1177/0333102419847749.
    PubMed     Text format     Abstract available
    
    
    
25. DEEN M, Martinelli D, Pijpers J, Diener HC, et al
    Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults.
    Cephalalgia. 2019 May 1:333102419847751. doi: 10.1177/0333102419847751.
    PubMed     Text format     Abstract available
    
    
    April 2019
26. GOADSBY PJ, Paemeleire K, Broessner G, Brandes J, et al
    Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
    Cephalalgia. 2019 Apr 13:333102419835459. doi: 10.1177/0333102419835459.
    PubMed     Text format     Abstract available
    
    
    
27. ALBERS L, Kries RV, Straube A, Heinen F, et al
    Age- and sex-specific first health care use for migraine in 2016 in children and adolescents from prospectively collected health insurance data in Germany.
    Cephalalgia. 2019 Apr 11:333102419844543. doi: 10.1177/0333102419844543.
    PubMed     Text format     Abstract available
    
    
    
28. WEN KX, Ikram MA, Franco OH, Vernooij M, et al
    Association of migraine with calcification in major vessel beds: The Rotterdam Study.
    Cephalalgia. 2019 Apr 8:333102419843148. doi: 10.1177/0333102419843148.
    PubMed     Text format     Abstract available
    
    
    
29. ABU-ARAFEH I, Hershey AD, Diener HC, Tassorelli C, et al
    Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition.
    Cephalalgia. 2019 Apr 4:333102419842188. doi: 10.1177/0333102419842188.
    PubMed     Text format     Abstract available
    
    
    March 2019
30. TOLNER EA, Chen SP, Eikermann-Haerter K
    Current understanding of cortical structure and function in migraine.
    Cephalalgia. 2019 Mar 28:333102419840643. doi: 10.1177/0333102419840643.
    PubMed     Text format     Abstract available
    
    
    
31. KIELBASA W, Helton DL
    A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody.
    Cephalalgia. 2019 Mar 27:333102419840780. doi: 10.1177/0333102419840780.
    PubMed     Text format     Abstract available
    
    
    
32. CHONG CD, Peplinski J, Berisha V, Ross K, et al
    Differences in fibertract profiles between patients with migraine and those with persistent post-traumatic headache.
    Cephalalgia. 2019 Mar 26:333102418815650. doi: 10.1177/0333102418815650.
    PubMed     Text format     Abstract available
    
    
    
33. ZHU B, Coppola G, Shoaran M
    Migraine classification using somatosensory evoked potentials.
    Cephalalgia. 2019 Mar 26:333102419839975. doi: 10.1177/0333102419839975.
    PubMed     Text format     Abstract available
    
    
    
34. HAGEN K, Hopstock LA, Elise Eggen A, Mathiesen EB, et al
    Does insomnia modify the association between C-reactive protein and migraine? The Tromso Study 2015-2016.
    Cephalalgia. 2019 Mar 12:333102418825370. doi: 10.1177/0333102418825370.
    PubMed     Text format     Abstract available
    
    
    
35. HOULE TT, Turner DP
    The vast potential of claims data to reduce undiagnosed chronic migraine.
    Cephalalgia. 2019 Mar 9:333102419836479. doi: 10.1177/0333102419836479.
    PubMed     Text format    
    
    
    
36. PAVLOVIC JM, Yu JS, Silberstein SD, Reed ML, et al
    Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients.
    Cephalalgia. 2019 Mar 9:333102418825373. doi: 10.1177/0333102418825373.
    PubMed     Text format     Abstract available
    
    
    
37. LEREBOURS F, Boulanouar K, Barege M, Denuelle M, et al
    Functional connectivity of hypothalamus in chronic migraine with medication overuse.
    Cephalalgia. 2019 Mar 5:333102419833087. doi: 10.1177/0333102419833087.
    PubMed     Text format     Abstract available
    
    
    
38. EDVINSSON L, Goadsby PJ
    Discovery of CGRP in relation to migraine.
    Cephalalgia. 2019;39:331-332.
    PubMed     Text format    
    
    
    February 2019
39. BONAFEDE M, Wilson K, Xue F
    Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine.
    Cephalalgia. 2019 Feb 28:333102419835465. doi: 10.1177/0333102419835465.
    PubMed     Text format     Abstract available
    
    
    
40. DIENER HC, Tassorelli C, Dodick DW, Silberstein SD, et al
    Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.
    Cephalalgia. 2019 Feb 26:333102419828967. doi: 10.1177/0333102419828967.
    PubMed     Text format     Abstract available
    
    
    
41. ABBASI M, Noori-Zadeh A, Seidkhani-Nahal A, Kaffashian M, et al
    Leptin, adiponectin, and resistin blood adipokine levels in migraineurs: Systematic reviews and meta-analyses.
    Cephalalgia. 2019 Feb 24:333102418807182. doi: 10.1177/0333102418807182.
    PubMed     Text format     Abstract available
    
    
    
42. XU D, Chen D, Zhu LN, Tan G, et al
    Safety and tolerability of calcitonin-gene-related peptide binding monoclonal antibodies for the prevention of episodic migraine - a meta-analysis of randomized controlled trials.
    Cephalalgia. 2019 Feb 21:333102419829007. doi: 10.1177/0333102419829007.
    PubMed     Text format     Abstract available
    
    
    
43. SENG EK, Gelfand AA, Nicholson RA
    Assessing evidence-based medicine and opioid/barbiturate as first-line acute treatment of pediatric migraine and primary headache: A retrospective observational study of health systems data.
    Cephalalgia. 2019 Feb 20:333102419833080. doi: 10.1177/0333102419833080.
    PubMed     Text format     Abstract available
    
    
    
44. BOGDANOV VB, Bogdanova OV, Vigano A, Noirhomme Q, et al
    Increased cerebral responses to salient transitions between alternating stimuli in chronic migraine with medication overuse headache and during migraine attacks.
    Cephalalgia. 2019 Feb 20:333102418825359. doi: 10.1177/0333102418825359.
    PubMed     Text format     Abstract available
    
    
    
45. LISICKI M, D'Ostilio K, Coppola G, Parisi V, et al
    Age related metabolic modifications in the migraine brain.
    Cephalalgia. 2019 Feb 11:333102419828984. doi: 10.1177/0333102419828984.
    PubMed     Text format     Abstract available
    
    
    
46. DODICK DW, Reed ML, Fanning KM, Munjal S, et al
    Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study.
    Cephalalgia. 2019 Feb 7:333102418825346. doi: 10.1177/0333102418825346.
    PubMed     Text format     Abstract available
    
    
    
47. BORTE S, Zwart JA, Stensland SO, Hagen K, et al
    Parental migraine in relation to migraine in offspring: Family linkage analyses from the HUNT Study.
    Cephalalgia. 2019 Feb 2:333102419828989. doi: 10.1177/0333102419828989.
    PubMed     Text format     Abstract available
    
    
    January 2019
48. DODICK DW
    CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
    Cephalalgia. 2019 Jan 19:333102418821662. doi: 10.1177/0333102418821662.
    PubMed     Text format     Abstract available
    
    
    
49. MARTAMI F, Togha M, Seifishahpar M, Ghorbani Z, et al
    The effects of a multispecies probiotic supplement on inflammatory markers and episodic and chronic migraine characteristics: A randomized double-blind controlled trial.
    Cephalalgia. 2019 Jan 8:333102418820102. doi: 10.1177/0333102418820102.
    PubMed     Text format     Abstract available
    
    
    
50. HAJIHASHEMI P, Askari G, Khorvash F, Reza Maracy M, et al
    The effects of concurrent Coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial.
    Cephalalgia. 2019 Jan 6:333102418821661. doi: 10.1177/0333102418821661.
    PubMed     Text format     Abstract available
    
    
    
51. INAN LE, Inan N, Unal-Artik HA, Atac C, et al
    Greater occipital nerve block in migraine prophylaxis: Narrative review.
    Cephalalgia. 2019 Jan 6:333102418821669. doi: 10.1177/0333102418821669.
    PubMed     Text format     Abstract available
    
    
    December 2018
52. MAGON S, May A, Stankewitz A, Goadsby PJ, et al
    Cortical abnormalities in episodic migraine: A multi-center 3T MRI study.
    Cephalalgia. 2018 Dec 10:333102418795163. doi: 10.1177/0333102418795163.
    PubMed     Text format     Abstract available
    
    
    November 2018
53. PETRUSIC I, Viana M, Dakovic M, J Goadsby P, et al
    Proposal for a Migraine Aura Complexity Score.
    Cephalalgia. 2018 Nov 20:333102418815487. doi: 10.1177/0333102418815487.
    PubMed     Text format     Abstract available
    
    
    
54. CHOU DE, Shnayderman Yugrakh M, Winegarner D, Rowe V, et al
    Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.
    Cephalalgia. 2018 Nov 17:333102418811573. doi: 10.1177/0333102418811573.
    PubMed     Text format     Abstract available
    
    
    
55. SCHWEDT TJ, Peplinski J, Garcia-Filion P, Berisha V, et al
    Altered speech with migraine attacks: A prospective, longitudinal study of episodic migraine without aura.
    Cephalalgia. 2018 Nov 17:333102418815505. doi: 10.1177/0333102418815505.
    PubMed     Text format     Abstract available
    
    
    October 2018
56. CARPENET C, Guichard E, Tzourio C, Kurth T, et al
    Self-perceived attention deficit and hyperactivity symptom levels and risk of non-migraine and migraine headaches among university students: A cross-sectional study.
    Cephalalgia. 2018 Oct 22:333102418804155. doi: 10.1177/0333102418804155.
    PubMed     Text format     Abstract available
    
    
    
57. GOLLION C, Nasr N, Fabre N, Barege M, et al
    Cerebral autoregulation in migraine with aura: A case control study.
    Cephalalgia. 2018 Oct 8:333102418806861. doi: 10.1177/0333102418806861.
    PubMed     Text format     Abstract available
    
    
    
58. NATION KM, Dodick DW, Navratilova E, Porreca F, et al
    Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache.
    Cephalalgia. 2018 Oct 4:333102418804157. doi: 10.1177/0333102418804157.
    PubMed     Text format     Abstract available
    
    
    September 2018
59. VO P, Wen S, Martel MJ, Mitsikostas D, et al
    Benefit-risk assessment of erenumab and current migraine prophylactic treatments using the likelihood of being helped or harmed.
    Cephalalgia. 2018 Sep 19:333102418801579. doi: 10.1177/0333102418801579.
    PubMed     Text format     Abstract available
    
    
    
60. GRAZZI L, Raggi A, D'Amico D, Sansone E, et al
    A prospective pilot study of the effect on catecholamines of mindfulness training vs pharmacological prophylaxis in patients with chronic migraine and medication overuse headache.
    Cephalalgia. 2018 Sep 13:333102418801584. doi: 10.1177/0333102418801584.
    PubMed     Text format     Abstract available
    
    
    August 2018
61. VOLLESEN LH, Guo S, Andersen MR, Ashina M, et al
    Effect of the H1-antihistamine clemastine on PACAP38 induced migraine.
    Cephalalgia. 2018 Aug 30:333102418798611. doi: 10.1177/0333102418798611.
    PubMed     Text format     Abstract available
    
    
    
62. SUSSMAN M, Benner J, Neumann P, Menzin J, et al
    Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives.
    Cephalalgia. 2018 Aug 24:333102418796842. doi: 10.1177/0333102418796842.
    PubMed     Text format     Abstract available
    
    
    
63. LAURITSEN CG, Silberstein SD
    Rationale for electrical parameter determination in external trigeminal nerve stimulation (eTNS) for migraine: A narrative review.
    Cephalalgia. 2018 Aug 23:333102418796781. doi: 10.1177/0333102418796781.
    PubMed     Text format     Abstract available
    
    
    
64. FUGLSANG CH, Johansen T, Kaila K, Kasch H, et al
    Treatment of acute migraine by a partial rebreathing device: A randomized controlled pilot study.
    Cephalalgia. 2018 Aug 22:333102418797285. doi: 10.1177/0333102418797285.
    PubMed     Text format     Abstract available
    
    
    
65. STARIKOVA NL, Baidina TV, Kalashnikova TP
    Thyrotropin levels and severity of symptoms in migraine patients of tertiary headache center.
    Cephalalgia. 2018 Aug 13:333102418794941. doi: 10.1177/0333102418794941.
    PubMed     Text format     Abstract available
    
    
    
66. PARK JH, Park KA, Cha J, Kim ST, et al
    A case report of isolated orbital vasculitis mimicking retinal migraine: A potential cause of recurrent transient monocular blindness and ipsilateral headache.
    Cephalalgia. 2018 Aug 12:333102418794482. doi: 10.1177/0333102418794482.
    PubMed     Text format     Abstract available
    
    
    
67. STRUPF M, Fraunberger B, Messlinger K, Namer B, et al
    Cyclic changes in sensations to painful stimuli in migraine patients.
    Cephalalgia. 2018 Aug 12:333102418793641. doi: 10.1177/0333102418793641.
    PubMed     Text format     Abstract available
    
    
    
68. PELLERIN A, Marois C, Mezouar N, Mokhtari K, et al
    Neuronal injuries evidenced by transient cortical magnetic resonance enhancement in hemiplegic migraine: A case report.
    Cephalalgia. 2018 Aug 9:333102418794481. doi: 10.1177/0333102418794481.
    PubMed     Text format     Abstract available
    
    
    
69. DEEN M, Hougaard A, Hansen HD, Svarer C, et al
    Migraine is associated with high brain 5-HT levels as indexed by 5-HT4 receptor binding.
    Cephalalgia. 2018 Aug 8:333102418793642. doi: 10.1177/0333102418793642.
    PubMed     Text format     Abstract available
    
    
    
70. BUSE DC, Lipton RB, Hallstrom Y, Reuter U, et al
    Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.
    Cephalalgia. 2018 Aug 7:333102418789072. doi: 10.1177/0333102418789072.
    PubMed     Text format     Abstract available
    
    
    
71. ALBERS L, von Kries R, Straube A, Heinen F, et al
    Do pre-school episodic syndromes predict migraine in primary school children? A retrospective cohort study on health care data.
    Cephalalgia. 2018 Aug 4:333102418791820. doi: 10.1177/0333102418791820.
    PubMed     Text format     Abstract available
    
    
    
72. YOUNIS S, Hougaard A, Noseda R, Ashina M, et al
    Current understanding of thalamic structure and function in migraine.
    Cephalalgia. 2018 Aug 4:333102418791595. doi: 10.1177/0333102418791595.
    PubMed     Text format     Abstract available
    
    
    May 2018
73. RAMACHANDRAN R, Pedersen SH, Amrutkar DV, Petersen S, et al
    Selective cephalic upregulation of p-ERK, CamKII and p-CREB in response to glyceryl trinitrate infusion.
    Cephalalgia. 2018;38:1057-1070.
    PubMed     Text format     Abstract available
    
    
    April 2018
74. FRIED NT, Maxwell CR, Elliott MB, Oshinsky ML, et al
    Region-specific disruption of the blood-brain barrier following repeated inflammatory dural stimulation in a rat model of chronic trigeminal allodynia.
    Cephalalgia. 2018;38:674-689.
    PubMed     Text format     Abstract available
    
    
    
75. GOADSBY PJ, Dodick DW, Lipton RB
    Re: Placebo responses in device studies.
    Cephalalgia. 2018;38:1007-1008.
    PubMed     Text format    
    
    
    February 2018
76. BRILLA R, Pawlowski M, Evers S
    Hemicrania continua in carotid artery dissection - symptomatic cases or linked pathophysiology?
    Cephalalgia. 2018;38:402-405.
    PubMed     Text format     Abstract available
    
    
    
77. ASHINA H, Schytz HW, Ashina M
    CGRP in human models of primary headaches.
    Cephalalgia. 2018;38:353-360.
    PubMed     Text format     Abstract available
    
    
    
78. ZANCHIN G, Fuccaro M, Battistella P, Ermani M, et al
    A lost track in ICHD 3 beta: A comprehensive review on osmophobia.
    Cephalalgia. 2018;38:340-352.
    PubMed     Text format     Abstract available
    
    
    January 2018
79. OAKES TMM, Skljarevsuki V, Zhang Q, Kielbasa W, et al
    Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study.
    Cephalalgia. 2018 Jan 1:333102417747230. doi: 10.1177/0333102417747230.
    PubMed     Text format     Abstract available
    
    
    
80. KROLL LS, Hammarlund CS, Linde M, Gard G, et al
    The effects of aerobic exercise for persons with migraine and co-existing tension-type headache and neck pain. A randomized, controlled, clinical trial.
    Cephalalgia. 2018 Jan 1:333102417752119. doi: 10.1177/0333102417752119.
    PubMed     Text format     Abstract available
    
    
    
81. KROS L, Angueyra Aristizabal CA, Khodakhah K
    Cerebellar involvement in migraine.
    Cephalalgia. 2018 Jan 1:333102417752120. doi: 10.1177/0333102417752120.
    PubMed     Text format     Abstract available
    
    
    
82. RIST PM, Winter AC, Buring JE, Sesso HD, et al
    Migraine and the risk of incident hypertension among women.
    Cephalalgia. 2018 Jan 1:333102418756865. doi: 10.1177/0333102418756865.
    PubMed     Text format     Abstract available
    
    
    
83. SANTANGELO G, Russo A, Tessitore A, Garramone F, et al
    Prospective memory is dysfunctional in migraine without aura.
    Cephalalgia. 2018 Jan 1:333102418758280. doi: 10.1177/0333102418758280.
    PubMed     Text format     Abstract available
    
    
    
84. HOLLAND PR, Saengjaroentham C, Vila-Pueyo M
    The role of the brainstem in migraine: Potential brainstem effects of CGRP and CGRP receptor activation in animal models.
    Cephalalgia. 2018 Jan 1:333102418756863. doi: 10.1177/0333102418756863.
    PubMed     Text format     Abstract available
    
    
    
85. TFELT-HANSEN P, Lindqvist JK, Do TP
    Evaluating the reporting of adverse events in controlled clinical trials conducted in 2010-2015 on migraine drug treatments.
    Cephalalgia. 2018 Jan 1:333102418759785. doi: 10.1177/0333102418759785.
    PubMed     Text format     Abstract available
    
    
    
86. HIEKKALA ME, Vuola P, Artto V, Happola P, et al
    The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: A clinical and genetic study in Finnish migraine families.
    Cephalalgia. 2018 Jan 1:333102418761041. doi: 10.1177/0333102418761041.
    PubMed     Text format     Abstract available
    
    
    
87. DODICK DW, Ashina M, Brandes JL, Kudrow D, et al
    ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
    Cephalalgia. 2018 Jan 1:333102418759786. doi: 10.1177/0333102418759786.
    PubMed     Text format     Abstract available
    
    
    
88. HAGEN K, Asberg AN, Stovner L, Linde M, et al
    Lifestyle factors and risk of migraine and tension-type headache. Follow-up data from the Nord-Trondelag Health Surveys 1995-1997 and 2006-2008.
    Cephalalgia. 2018 Jan 1:333102418764888. doi: 10.1177/0333102418764888.
    PubMed     Text format     Abstract available
    
    
    
89. STARLING AJ, Tepper SJ, Marmura MJ, Shamim EA, et al
    A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).
    Cephalalgia. 2018 Jan 1:333102418762525. doi: 10.1177/0333102418762525.
    PubMed     Text format     Abstract available
    
    
    
90. TASSORELLI C, Diener HC, Dodick DW, Silberstein SD, et al
    Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.
    Cephalalgia. 2018 Jan 1:333102418758283. doi: 10.1177/0333102418758283.
    PubMed     Text format     Abstract available
    
    
    
91. ERDAL Y, Emre U, Cimen Atalar A, Gunes T, et al
    Alien hand syndrome and migraine with aura: A case report.
    Cephalalgia. 2018 Jan 1:333102418763321. doi: 10.1177/0333102418763321.
    PubMed     Text format     Abstract available
    
    
    
92. RENTHAL W
    Localization of migraine susceptibility genes in human brain by single-cell RNA sequencing.
    Cephalalgia. 2018 Jan 1:333102418762476. doi: 10.1177/0333102418762476.
    PubMed     Text format     Abstract available
    
    
    
93. GHANIZADA H, Arngrim N, Schytz HW, Olesen J, et al
    Carbon monoxide inhalation induces headache but no migraine in patients with migraine without aura.
    Cephalalgia. 2018 Jan 1:333102418765771. doi: 10.1177/0333102418765771.
    PubMed     Text format     Abstract available
    
    
    
94. EVANS RW
    Episodic daily migraine or episodic status migrainosus.
    Cephalalgia. 2018 Jan 1:333102418766869. doi: 10.1177/0333102418766869.
    PubMed     Text format    
    
    
    
95. GELFAND JM, Gelfand AA, Goadsby PJ, Benn BS, et al
    Migraine is common in patients with sarcoidosis.
    Cephalalgia. 2018 Jan 1:333102418768037. doi: 10.1177/0333102418768037.
    PubMed     Text format     Abstract available
    
    
    
96. MESSINA R, Goadsby PJ
    CGRP - a target for acute therapy in migraine: Clinical data.
    Cephalalgia. 2018 Jan 1:333102418768095. doi: 10.1177/0333102418768095.
    PubMed     Text format     Abstract available
    
    
    
97. CARVALHO GF, Vianna-Bell FH, Florencio LL, Pinheiro CF, et al
    Presence of vestibular symptoms and related disability in migraine with and without aura and chronic migraine.
    Cephalalgia. 2018 Jan 1:333102418769948. doi: 10.1177/0333102418769948.
    PubMed     Text format     Abstract available
    
    
    
98. RAMSEY RR, Holbein CE, Powers SW, Hershey AD, et al
    A pilot investigation of a mobile phone application and progressive reminder system to improve adherence to daily prevention treatment in adolescents and young adults with migraine.
    Cephalalgia. 2018 Jan 1:333102418756864. doi: 10.1177/0333102418756864.
    PubMed     Text format     Abstract available
    
    
    
99. VIANA M, Bottiroli S, Sances G, Ghiotto N, et al
    Factors associated to chronic migraine with medication overuse: A cross-sectional study.
    Cephalalgia. 2018 Jan 1:333102418761047. doi: 10.1177/0333102418761047.
    PubMed     Text format     Abstract available
    
    
    
100. AHMED M, Boyd C, Vavilikolanu R, Rafique B, et al
     Visual symptoms and childhood migraine: Qualitative analysis of duration, location, spread, mobility, colour and pattern.
     Cephalalgia. 2018 Jan 1:333102418766872. doi: 10.1177/0333102418766872.
     PubMed     Text format     Abstract available
     
     
     
101. TERRIN A, Toldo G, Ermani M, Mainardi F, et al
     When migraine mimics stroke: A systematic review.
     Cephalalgia. 2018 Jan 1:333102418767999. doi: 10.1177/0333102418767999.
     PubMed     Text format     Abstract available
     
     
     
102. PURDY RA, Diener HC
     Migraine mimicking stroke: What to do?
     Cephalalgia. 2018 Jan 1:333102418768087. doi: 10.1177/0333102418768087.
     PubMed     Text format    
     
     
     
103. CLOSE LN, Eftekhari S, Wang M, Charles AC, et al
     Cortical spreading depression as a site of origin for migraine: Role of CGRP.
     Cephalalgia. 2018 Jan 1:333102418774299. doi: 10.1177/0333102418774299.
     PubMed     Text format     Abstract available
     
     
     
104. ANGUS-LEPPAN H, Caulfield A
     Orgasmic migraine aura: Report of two cases.
     Cephalalgia. 2018 Jan 1:333102418771373. doi: 10.1177/0333102418771373.
     PubMed     Text format     Abstract available
     
     
     
105. RUBINO E, Rainero I, Garino F, Vicentini C, et al
     Subclinical hypothyroidism is associated with migraine: A case-control study.
     Cephalalgia. 2018 Jan 1:333102418769917. doi: 10.1177/0333102418769917.
     PubMed     Text format     Abstract available
     
     
     
106. HALKER SINGH RB, Aycardi E, Bigal ME, Loupe PS, et al
     Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials.
     Cephalalgia. 2018 Jan 1:333102418772585. doi: 10.1177/0333102418772585.
     PubMed     Text format     Abstract available
     
     
     
107. LEVINSKY Y, Zeharia A, Eidlitz-Markus T
     Cephalic cutaneous allodynia in children and adolescents with migraine of short duration: A retrospective cohort study.
     Cephalalgia. 2018 Jan 1:333102418776018. doi: 10.1177/0333102418776018.
     PubMed     Text format     Abstract available
     
     
     
108. MOYE LS, Novack ML, Tipton AF, Krishnan H, et al
     The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target.
     Cephalalgia. 2018 Jan 1:333102418777507. doi: 10.1177/0333102418777507.
     PubMed     Text format     Abstract available
     
     
     
109. MARTINS LB, Rodrigues AMDS, Rodrigues DF, Dos Santos LC, et al
     Double-blind placebo-controlled randomized clinical trial of ginger ( Zingiber officinale Rosc.) addition in migraine acute treatment.
     Cephalalgia. 2018 Jan 1:333102418776016. doi: 10.1177/0333102418776016.
     PubMed     Text format     Abstract available
     
     
     
110. DE HOON J, Van Hecken A, Vandermeulen C, Herbots M, et al
     Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers.
     Cephalalgia. 2018 Jan 1:333102418776017. doi: 10.1177/0333102418776017.
     PubMed     Text format     Abstract available
     
     
     
111. HASSLER SN, Ahmad FB, Burgos-Vega CC, Boitano S, et al
     Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice.
     Cephalalgia. 2018 Jan 1:333102418779548. doi: 10.1177/0333102418779548.
     PubMed     Text format     Abstract available
     
     
     
112. BURGOS-VEGA CC, Quigley LD, Trevisan Dos Santos G, Yan F, et al
     Non-invasive dural stimulation in mice: A novel preclinical model of migraine.
     Cephalalgia. 2018 Jan 1:333102418779557. doi: 10.1177/0333102418779557.
     PubMed     Text format     Abstract available
     
     
     
113. SKLJAREVSKI V, Matharu M, Millen BA, Ossipov MH, et al
     Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial.
     Cephalalgia. 2018 Jan 1:333102418779543. doi: 10.1177/0333102418779543.
     PubMed     Text format     Abstract available
     
     
     
114. ABDOLLAHPOUR I, Salimi Y
     Subclinical hypothyroidism is associated with migraine: A case-control study; methodological and statistical issues.
     Cephalalgia. 2018 Jan 1:333102418779542. doi: 10.1177/0333102418779542.
     PubMed     Text format    
     
     
     
115. CORTESE F, Pierelli F, Pauri F, Di Lorenzo C, et al
     Short-term cortical synaptic depression/potentiation mechanisms in chronic migraine patients with or without medication overuse.
     Cephalalgia. 2018 Jan 1:333102418784747. doi: 10.1177/0333102418784747.
     PubMed     Text format     Abstract available
     
     
     
116. PELZER N, Louter MA, van Zwet EW, Nyholt DR, et al
     Linking migraine frequency with family history of migraine.
     Cephalalgia. 2018 Jan 1:333102418783295. doi: 10.1177/0333102418783295.
     PubMed     Text format     Abstract available
     
     
     
117. LEVY D, Labastida-Ramirez A, MaassenVanDenBrink A
     Current understanding of meningeal and cerebral vascular function underlying migraine headache.
     Cephalalgia. 2018 Jan 1:333102418771350. doi: 10.1177/0333102418771350.
     PubMed     Text format     Abstract available
     
     
     
118. SCHER AI, Wang SJ, Katsarava Z, Buse DC, et al
     Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
     Cephalalgia. 2018 Jan 1:333102418786266. doi: 10.1177/0333102418786266.
     PubMed     Text format     Abstract available
     
     
     
119. ANTONACI F, Rossi E, Voiticovschi-Iosob C, Dalla Volta G, et al
     Frontal infrared thermography in healthy individuals and chronic migraine patients: Reliability of the method.
     Cephalalgia. 2018 Jan 1:333102418788341. doi: 10.1177/0333102418788341.
     PubMed     Text format     Abstract available
     
     
     
120. BERTELLI S, Barbieri R, Pusch M, Gavazzo P, et al
     Gain of function of sporadic/familial hemiplegic migraine-causing SCN1A mutations: Use of an optimized cDNA.
     Cephalalgia. 2018 Jan 1:333102418788336. doi: 10.1177/0333102418788336.
     PubMed     Text format     Abstract available
     
     
     
121. ASHINA M, Tepper S, Brandes JL, Reuter U, et al
     Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
     Cephalalgia. 2018 Jan 1:333102418788347. doi: 10.1177/0333102418788347.
     PubMed     Text format     Abstract available
     
     
     
122. PLATZBECKER K, Zhang MB, Kurth T, Rudolph MI, et al
     The association between migraine and hospital readmission due to pain after surgery: A hospital registry study.
     Cephalalgia. 2018 Jan 1:333102418786457. doi: 10.1177/0333102418786457.
     PubMed     Text format     Abstract available
     
     
     
123. SEAV SM, Schuster NM
     Cluster-status migrainosus with a weekly periodicity responsive to high-flow oxygen: A case report.
     Cephalalgia. 2018 Jan 1:333102418787263. doi: 10.1177/0333102418787263.
     PubMed     Text format     Abstract available
     
     
     May 2017
124. HANSEN AG, Stovner LJ, Hagen K, Helvik AS, et al
     Paranasal sinus opacification in headache sufferers: A population-based imaging study (the HUNT study-MRI).
     Cephalalgia. 2017;37:509-516.
     PubMed     Text format     Abstract available
     
     
     April 2017
125. BRITZE J, Arngrim N, Schytz HW, Ashina M, et al
     Hypoxic mechanisms in primary headaches.
     Cephalalgia. 2017;37:372-384.
     PubMed     Text format     Abstract available
     
     
     February 2017
126. PIOVESAN EJ, Kowacs PA
     A path for two destinations.
     Cephalalgia. 2017;37:199.
     PubMed     Text format    
     
     
     January 2017
127. PRONTERA P, Sarchielli P, Caproni S, Bedetti C, et al
     Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications.
     Cephalalgia. 2017 Jan 1:333102416686347. doi: 10.1177/0333102416686347.
     PubMed     Text format     Abstract available
     
     
     
128. GERRING ZF, Powell JE, Montgomery GW, Nyholt DR, et al
     Genome-wide analysis of blood gene expression in migraine implicates immune-inflammatory pathways.
     Cephalalgia. 2017 Jan 1:333102416686769. doi: 10.1177/0333102416686769.
     PubMed     Text format     Abstract available
     
     
     
129. SINGH TD, Cutrer FM, Smith JH
     Episodic status migrainosus: A novel migraine subtype.
     Cephalalgia. 2017 Jan 1:333102416686341. doi: 10.1177/0333102416686341.
     PubMed     Text format     Abstract available
     
     
     
130. DE AMORIM IL, Antunes AP, Nunes GS, Martins IP, et al
     Reversible cortical thickening in hemiplegic migraine.
     Cephalalgia. 2017 Jan 1:333102417690128. doi: 10.1177/0333102417690128.
     PubMed     Text format    
     
     
     
131. TAGA A, Russo M, Genovese A, Manzoni GC, et al
     A case-report of migraine "sine headache".
     Cephalalgia. 2017 Jan 1:333102417690892. doi: 10.1177/0333102417690892.
     PubMed     Text format     Abstract available
     
     
     
132. RAMOS ML, Garcia-Cabo C, Leira R, Dominguez C, et al
     Comorbidity between idiopathic overactive bladder and chronic migraine.
     Cephalalgia. 2017 Jan 1:333102417690127. doi: 10.1177/0333102417690127.
     PubMed     Text format     Abstract available
     
     
     
133. HAGEN K, Asvold BO, Midthjell K, Stovner LJ, et al
     Inverse relationship between type 1 diabetes mellitus and migraine. Data from the Nord-Trondelag Health Surveys 1995-1997 and 2006-2008.
     Cephalalgia. 2017 Jan 1:333102417690488. doi: 10.1177/0333102417690488.
     PubMed     Text format     Abstract available
     
     
     
134. CHAUVEL V, Multon S, Schoenen J
     Estrogen-dependent effects of 5-hydroxytryptophan on cortical spreading depression in rat: Modelling the serotonin-ovarian hormone interaction in migraine aura.
     Cephalalgia. 2017 Jan 1:333102417690891. doi: 10.1177/0333102417690891.
     PubMed     Text format     Abstract available
     
     
     
135. MCILVRIED LA, Cruz JA, Borghesi LA, Gold MS, et al
     Sex-, stress-, and sympathetic post-ganglionic-dependent changes in identity and proportions of immune cells in the dura.
     Cephalalgia. 2017;37:36-48.
     PubMed     Text format     Abstract available
     
     
     
136. CORTEZ MM, Rea NA, Hunter LA, Digre KB, et al
     Altered pupillary light response scales with disease severity in migrainous photophobia.
     Cephalalgia. 2017 Jan 1:333102416673205. doi: 10.1177/0333102416673205.
     PubMed     Text format     Abstract available
     
     
     
137. PALM-MEINDERS IH, Koppen H, Terwindt GM, Launer LJ, et al
     Iron in deep brain nuclei in migraine? CAMERA follow-up MRI findings.
     Cephalalgia. 2017 Jan 1:333102416668654. doi: 10.1177/0333102416668654.
     PubMed     Text format     Abstract available
     
     
     
138. XIE JY, De Felice M, Kopruszinski CM, Eyde N, et al
     Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.
     Cephalalgia. 2017 Jan 1:333102417702120. doi: 10.1177/0333102417702120.
     PubMed     Text format     Abstract available
     
     
     
139. LEBEDEVA ER, Gurary NM, Gilev DV, Olesen J, et al
     Prospective testing of ICHD-3 beta diagnostic criteria for migraine with aura and migraine with typical aura in patients with transient ischemic attacks.
     Cephalalgia. 2017 Jan 1:333102417702121. doi: 10.1177/0333102417702121.
     PubMed     Text format     Abstract available
     
     
     
140. SILVA-NETO RP, Rodrigues AB, Cavalcante DC, Ferreira PHPB, et al
     Reply to the Letter to the Editor: "Smell of migraine: Osmophobia as a clinical diagnostic marker".
     Cephalalgia. 2017 Jan 1:333102416658716. doi: 10.1177/0333102416658716.
     PubMed     Text format    
     
     
     
141. WEN KX, Mutlu U, Ikram MK, Kavousi M, et al
     The retinal microcirculation in migraine: The Rotterdam Study.
     Cephalalgia. 2017 Jan 1:333102417708774. doi: 10.1177/0333102417708774.
     PubMed     Text format     Abstract available
     
     
     
142. SAMPAIO ROCHA-FILHO PA
     Episodic status migrainosus: One more case.
     Cephalalgia. 2017 Jan 1:333102417710021. doi: 10.1177/0333102417710021.
     PubMed     Text format    
     
     
     
143. GOULART AC, Lotufo PA, Santos IS, Bittencourt MS, et al
     The relationship between migraine and lipid sub-fractions among individuals without cardiovascular disease: A cross-sectional evaluation in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
     Cephalalgia. 2017 Jan 1:333102417699181. doi: 10.1177/0333102417699181.
     PubMed     Text format     Abstract available
     
     
     
144. MYKLAND MS, Bjork MH, Stjern M, Sand T, et al
     Alterations in post-movement beta event related synchronization throughout the migraine cycle: A controlled, longitudinal study.
     Cephalalgia. 2017 Jan 1:333102417709011. doi: 10.1177/0333102417709011.
     PubMed     Text format     Abstract available
     
     
     
145. MARTIN VT, Allen JR, Houle TT, Powers SW, et al
     Ovarian hormones, age and pubertal development and their association with days of headache onset in girls with migraine: An observational cohort study.
     Cephalalgia. 2017 Jan 1:333102417706980. doi: 10.1177/0333102417706980.
     PubMed     Text format     Abstract available
     
     
     
146. WANG SB, Liu KD, Yang Y, Li YJ, et al
     Prevalence and extent of right-to-left shunt on contrast-enhanced transcranial Doppler in Chinese patients with migraine in a multicentre case-control study.
     Cephalalgia. 2017 Jan 1:333102417708203. doi: 10.1177/0333102417708203.
     PubMed     Text format     Abstract available
     
     
     
147. HSIAO FJ, Wang SJ, Lin YY, Fuh JL, et al
     Somatosensory gating is altered and associated with migraine chronification: A magnetoencephalographic study.
     Cephalalgia. 2017 Jan 1:333102417712718. doi: 10.1177/0333102417712718.
     PubMed     Text format     Abstract available
     
     
     
148. DALLEL R, Descheemaeker A, Luccarini P
     Recurrent administration of the nitric oxide donor, isosorbide dinitrate, induces a persistent cephalic cutaneous hypersensitivity: A model for migraine progression.
     Cephalalgia. 2017 Jan 1:333102417714032. doi: 10.1177/0333102417714032.
     PubMed     Text format     Abstract available
     
     
     
149. WARHURST S, Rofe CJ, Brew BJ, Bateson D, et al
     Effectiveness of the progestin-only pill for migraine treatment in women: A systematic review and meta-analysis.
     Cephalalgia. 2017 Jan 1:333102417710636. doi: 10.1177/0333102417710636.
     PubMed     Text format     Abstract available
     
     
     
150. KAYAMA Y, Shibata M, Takizawa T, Ibata K, et al
     Functional interactions between transient receptor potential M8 and transient receptor potential V1 in the trigeminal system: Relevance to migraine pathophysiology.
     Cephalalgia. 2017 Jan 1:333102417712719. doi: 10.1177/0333102417712719.
     PubMed     Text format     Abstract available
     
     
     
151. COPPOLA G, Di Renzo A, Tinelli E, Di Lorenzo C, et al
     Resting state connectivity between default mode network and insula encodes acute migraine headache.
     Cephalalgia. 2017 Jan 1:333102417715230. doi: 10.1177/0333102417715230.
     PubMed     Text format     Abstract available
     
     
     
152. SONG TJ, Yun CH, Cho SJ, Kim WJ, et al
     Short sleep duration and poor sleep quality among migraineurs: A population-based study.
     Cephalalgia. 2017 Jan 1:333102417716936. doi: 10.1177/0333102417716936.
     PubMed     Text format     Abstract available
     
     
     
153. LUEDTKE K, Starke W, May A
     Musculoskeletal dysfunction in migraine patients.
     Cephalalgia. 2017 Jan 1:333102417716934. doi: 10.1177/0333102417716934.
     PubMed     Text format     Abstract available
     
     
     
154. CHARLESTON IV L, Burke JF
     Do racial/ethnic disparities exist in recommended migraine treatments in US ambulatory care?
     Cephalalgia. 2017 Jan 1:333102417716933. doi: 10.1177/0333102417716933.
     PubMed     Text format     Abstract available
     
     
     
155. DOMINGUEZ C, Vieites-Prado A, Perez-Mato M, Sobrino T, et al
     Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study.
     Cephalalgia. 2017 Jan 1:333102417720213. doi: 10.1177/0333102417720213.
     PubMed     Text format     Abstract available
     
     
     
156. KHAN S, Deen M, Hougaard A, Amin FM, et al
     Reproducibility of migraine-like attacks induced by phosphodiesterase-3-inhibitor cilostazol.
     Cephalalgia. 2017 Jan 1:333102417719753. doi: 10.1177/0333102417719753.
     PubMed     Text format     Abstract available
     
     
     
157. LISICKI M, Ruiz-Romagnoli E, Piedrabuena R, Giobellina R, et al
     Migraine triggers and habituation of visual evoked potentials.
     Cephalalgia. 2017 Jan 1:333102417720217. doi: 10.1177/0333102417720217.
     PubMed     Text format     Abstract available
     
     
     
158. KRISTOFFERSEN ES, Stavem K, Lundqvist C, Russell MB, et al
     Excessive daytime sleepiness in chronic migraine and chronic tension-type headache from the general population.
     Cephalalgia. 2017 Jan 1:333102417721133. doi: 10.1177/0333102417721133.
     PubMed     Text format     Abstract available
     
     
     
159. VINOGRADOVA LV
     Initiation of spreading depression by synaptic and network hyperactivity: Insights into trigger mechanisms of migraine aura.
     Cephalalgia. 2017 Jan 1:333102417724151. doi: 10.1177/0333102417724151.
     PubMed     Text format     Abstract available
     
     
     
160. PELZER N, Hoogeveen ES, Ferrari MD, Poll-The BT, et al
     Brain atrophy following hemiplegic migraine attacks.
     Cephalalgia. 2017 Jan 1:333102417723569. doi: 10.1177/0333102417723569.
     PubMed     Text format     Abstract available
     
     
     
161. BUONFIGLIO M, Di Sabato F
     Lack of habituation of visual evoked potentials in migraine and healthy subjects: Correlated cognitive behavioral aspects.
     Cephalalgia. 2017 Jan 1:333102417724153. doi: 10.1177/0333102417724153.
     PubMed     Text format    
     
     
     
162. CADIOT D, Longuet R, Bruneau B, Treguier C, et al
     Magnetic resonance imaging in children presenting migraine with aura: Association of hypoperfusion detected by arterial spin labelling and vasospasm on MR angiography findings.
     Cephalalgia. 2017 Jan 1:333102417723570. doi: 10.1177/0333102417723570.
     PubMed     Text format     Abstract available
     
     
     
163. DEEN M, Hansen HD, Hougaard A, da Cunha-Bang S, et al
     Low 5-HT1B receptor binding in the migraine brain: A PET study.
     Cephalalgia. 2017 Jan 1:333102417698708. doi: 10.1177/0333102417698708.
     PubMed     Text format     Abstract available
     
     
     
164. MAMOURI O, Cuvellier JC, Duhamel A, Vallee L, et al
     Postdrome symptoms in pediatric migraine: A questionnaire retrospective study by phone in 100 patients.
     Cephalalgia. 2017 Jan 1:333102417721132. doi: 10.1177/0333102417721132.
     PubMed     Text format     Abstract available
     
     
     
165. WILCOX SL, Ludwick AM, Lebel A, Borsook D, et al
     Age- and sex-related differences in the presentation of paediatric migraine: A retrospective cohort study.
     Cephalalgia. 2017 Jan 1:333102417722570. doi: 10.1177/0333102417722570.
     PubMed     Text format     Abstract available
     
     
     
166. VOLLONO C, Primiano G, Della Marca G, Losurdo A, et al
     Migraine in mitochondrial disorders: Prevalence and characteristics.
     Cephalalgia. 2017 Jan 1:333102417723568. doi: 10.1177/0333102417723568.
     PubMed     Text format     Abstract available
     
     
     
167. SPIELMANN K, Kayser A, Beck E, Meister R, et al
     Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study.
     Cephalalgia. 2017 Jan 1:333102417724152. doi: 10.1177/0333102417724152.
     PubMed     Text format     Abstract available
     
     
     
168. MATHARU M, Pascual J, Nilsson Remahl I, Straube A, et al
     Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe.
     Cephalalgia. 2017 Jan 1:333102417724150. doi: 10.1177/0333102417724150.
     PubMed     Text format     Abstract available
     
     
     
169. GRECO R, Demartini C, Zanaboni AM, Berliocchi L, et al
     Inhibition of monoacylglycerol lipase: Another signalling pathway for potential therapeutic targets in migraine?
     Cephalalgia. 2017 Jan 1:333102417727537. doi: 10.1177/0333102417727537.
     PubMed     Text format     Abstract available
     
     
     
170. ZHAO Y, Martins-Oliveira M, Akerman S, Goadsby PJ, et al
     Comparative effects of traditional Chinese and Western migraine medicines in an animal model of nociceptive trigeminovascular activation.
     Cephalalgia. 2017 Jan 1:333102417728245. doi: 10.1177/0333102417728245.
     PubMed     Text format     Abstract available
     
     
     
171. GUY N, Voisin D, Mulliez A, Clavelou P, et al
     Medication overuse reinstates conditioned pain modulation in women with migraine.
     Cephalalgia. 2017 Jan 1:333102417727545. doi: 10.1177/0333102417727545.
     PubMed     Text format     Abstract available
     
     
     
172. INDELICATO E, Nachbauer W, Eigentler A, Donnemiller E, et al
     Ten years of follow-up in a large family with familial hemiplegic migraine type 1: Clinical course and implications for treatment.
     Cephalalgia. 2017 Jan 1:333102417715229. doi: 10.1177/0333102417715229.
     PubMed     Text format     Abstract available
     
     
     
173. VECCHIO E, Gentile E, Franco G, Ricci K, et al
     Effects of external trigeminal nerve stimulation (eTNS) on laser evoked cortical potentials (LEP): A pilot study in migraine patients and controls.
     Cephalalgia. 2017 Jan 1:333102417728748. doi: 10.1177/0333102417728748.
     PubMed     Text format     Abstract available
     
     
     
174. GUERRERO-PERAL AL, Ruiz M, Baron J, Palacios-Cena M, et al
     Roller pressure algometry as a new tool for assessing dynamic pressure sensitivity in migraine.
     Cephalalgia. 2017 Jan 1:333102417729114. doi: 10.1177/0333102417729114.
     PubMed     Text format     Abstract available
     
     
     
175. LISICKI M, D'Ostilio K, Erpicum M, Schoenen J, et al
     Sunlight irradiance and habituation of visual evoked potentials in migraine: The environment makes its mark.
     Cephalalgia. 2017 Jan 1:333102417730128. doi: 10.1177/0333102417730128.
     PubMed     Text format     Abstract available
     
     
     
176. AMIN FM, Hougaard A, Magon S, Sprenger T, et al
     Altered thalamic connectivity during spontaneous attacks of migraine without aura: A resting-state fMRI study.
     Cephalalgia. 2017 Jan 1:333102417729113. doi: 10.1177/0333102417729113.
     PubMed     Text format     Abstract available
     
     
     
177. CHENG CY, Cheng HM, Chen SP, Chung CP, et al
     White matter hyperintensities in migraine: Clinical significance and central pulsatile hemodynamic correlates.
     Cephalalgia. 2017 Jan 1:333102417728751. doi: 10.1177/0333102417728751.
     PubMed     Text format     Abstract available
     
     
     
178. GIL-GOUVEIA R, Martins IP
     Clinical description of attack-related cognitive symptoms in migraine: A systematic review.
     Cephalalgia. 2017 Jan 1:333102417728250. doi: 10.1177/0333102417728250.
     PubMed     Text format     Abstract available
     
     
     
179. TIETJEN GE, Khubchandani J, Herial N, Palm-Meinders IH, et al
     Migraine and vascular disease biomarkers: A population-based case-control study.
     Cephalalgia. 2017 Jan 1:333102417698936. doi: 10.1177/0333102417698936.
     PubMed     Text format     Abstract available
     
     
     
180. MIN HJ, Kim KS
     Comment on: Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study.
     Cephalalgia. 2017 Jan 1:333102417731350. doi: 10.1177/0333102417731350.
     PubMed     Text format    
     
     
     
181. MIN HJ, Kim KS
     Comment on: Relationship between serum levels of VIP, but not of CGRP, and cranial autonomic parasympathetic symptoms: A study in chronic migraine patients.
     Cephalalgia. 2017 Jan 1:333102417731352. doi: 10.1177/0333102417731352.
     PubMed     Text format    
     
     
     
182. MIN HJ, Kim KS
     Comment on: Excessive daytime sleepiness in chronic migraine and chronic tension-type headache from the general population.
     Cephalalgia. 2017 Jan 1:333102417731354. doi: 10.1177/0333102417731354.
     PubMed     Text format    
     
     
     
183. CHRISTENSEN CE, Andersen FS, Wienholtz N, Egeberg A, et al
     The relationship between migraine and rosacea: Systematic review and meta-analysis.
     Cephalalgia. 2017 Jan 1:333102417731777. doi: 10.1177/0333102417731777.
     PubMed     Text format     Abstract available
     
     
     
184. CAO Z, Lai KL, Lin CT, Chuang CH, et al
     Exploring resting-state EEG complexity before migraine attacks.
     Cephalalgia. 2017 Jan 1:333102417733953. doi: 10.1177/0333102417733953.
     PubMed     Text format     Abstract available
     
     
     
185. OMLAND PM, Uglem M, Stovner LJ, Sand T, et al
     Visual and auditory cortical evoked potentials in interictal episodic migraine: The predictive value of a proposed diagnostic test should always be corrected for prevalence.
     Cephalalgia. 2017 Jan 1:333102417695797. doi: 10.1177/0333102417695797.
     PubMed     Text format    
     
     
     
186. MARCISZEWSKI KK, Meylakh N, Di Pietro F, Macefield VG, et al
     Altered brainstem anatomy in migraine.
     Cephalalgia. 2017 Jan 1:333102417694884. doi: 10.1177/0333102417694884.
     PubMed     Text format     Abstract available
     
     
     
187. HOLLAND PR, Strother L
     Cilostazol as a chemically induced preclinical model of migraine.
     Cephalalgia. 2017 Jan 1:333102417693832. doi: 10.1177/0333102417693832.
     PubMed     Text format    
     
     
     
188. IYIGUNDOGDU I, Derle E, Asena L, Kural F, et al
     Relationship between white matter hyperintensities and retinal nerve fiber layer, choroid, and ganglion cell layer thickness in migraine patients.
     Cephalalgia. 2017 Jan 1:333102417694882. doi: 10.1177/0333102417694882.
     PubMed     Text format     Abstract available
     
     
     
189. AMBROSINI A, Kisialiou A, Schoenen J
     Reply to the letter by Omland et al.: "Visual and auditory cortical evoked potentials in interictal episodic migraine: The predictive value of a proposed diagnostic test should always be corrected for prevalence".
     Cephalalgia. 2017 Jan 1:333102417695796. doi: 10.1177/0333102417695796.
     PubMed     Text format    
     
     
     
190. CHEN SP, Fuh JL, Chung MY, Lin YC, et al
     Genome-wide association study identifies novel susceptibility loci for migraine in Han Chinese resided in Taiwan.
     Cephalalgia. 2017 Jan 1:333102417695105. doi: 10.1177/0333102417695105.
     PubMed     Text format     Abstract available
     
     
     
191. CHRISTENSEN SL, Petersen S, Sorensen DB, Olesen J, et al
     Cilostazol induces C-fos expression in the trigeminal nucleus caudalis and behavioural changes suggestive of headache with the migraine-like feature photophobia in female rats.
     Cephalalgia. 2017 Jan 1:333102417693833. doi: 10.1177/0333102417693833.
     PubMed     Text format     Abstract available
     
     
     
192. KRAYA T, Mages S, Zierz S
     "Thoracic migraine" as a new manifestation of migraine: Case report.
     Cephalalgia. 2017 Jan 1:333102417733960. doi: 10.1177/0333102417733960.
     PubMed     Text format     Abstract available
     
     
     
193. VAN OOSTERHOUT W, van Someren E, Schoonman GG, Louter MA, et al
     Chronotypes and circadian timing in migraine.
     Cephalalgia. 2017 Jan 1:333102417698953. doi: 10.1177/0333102417698953.
     PubMed     Text format     Abstract available
     
     
     
194. BEN AISSA M, Tipton AF, Bertels Z, Gandhi R, et al
     Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
     Cephalalgia. 2017 Jan 1:333102417737778. doi: 10.1177/0333102417737778.
     PubMed     Text format     Abstract available
     
     
     
195. SPIERINGS EL, Brandes JL, Kudrow DB, Weintraub J, et al
     Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
     Cephalalgia. 2017 Jan 1:333102417737765. doi: 10.1177/0333102417737765.
     PubMed     Text format     Abstract available
     
     
     
196. EDVINSSON L, Warfvinge K
     Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
     Cephalalgia. 2017 Jan 1:333102417736900. doi: 10.1177/0333102417736900.
     PubMed     Text format     Abstract available
     
     
     
197. LEBEDEVA ER, Gurary NM, Gilev DV, Christensen AF, et al
     Explicit diagnostic criteria for transient ischemic attacks to differentiate it from migraine with aura.
     Cephalalgia. 2017 Jan 1:333102417736901. doi: 10.1177/0333102417736901.
     PubMed     Text format     Abstract available
     
     
     
198. UNEKAWA M, Ikeda K, Tomita Y, Kawakami K, et al
     Enhanced susceptibility to cortical spreading depression in two types of Na+,K+-ATPase alpha2 subunit-deficient mice as a model of familial hemiplegic migraine 2.
     Cephalalgia. 2017 Jan 1:333102417738249. doi: 10.1177/0333102417738249.
     PubMed     Text format     Abstract available
     
     
     
199. JERIC M, Surjan N, Jelicic Kadic A, Riva N, et al
     Treatment of acute migraine attacks in children with analgesics on the World Health Organization Essential Medicines List: A systematic review and GRADE evidence synthesis.
     Cephalalgia. 2017 Jan 1:333102417736902. doi: 10.1177/0333102417736902.
     PubMed     Text format     Abstract available
     
     
     
200. DOMINGUEZ C, Vieites-Prado A, Perez-Mato M, Sobrino T, et al
     Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study.
     Cephalalgia. 2017 Jan 1:333102417731351. doi: 10.1177/0333102417731351.
     PubMed     Text format    
     
     
     
201. PELLEGRINO BAENA C, Goulart AC, Santos IS, Suemoto CK, et al
     Migraine and cognitive function: Baseline findings from the Brazilian Longitudinal Study of Adult Health: ELSA-Brasil.
     Cephalalgia. 2017 Jan 1:333102417737784. doi: 10.1177/0333102417737784.
     PubMed     Text format     Abstract available
     
     
     
202. LABASTIDA-RAMIREZ A, Rubio-Beltran E, Villalon CM, MaassenVanDenBrink A, et al
     Gender aspects of CGRP in migraine.
     Cephalalgia. 2017 Jan 1:333102417739584. doi: 10.1177/0333102417739584.
     PubMed     Text format     Abstract available
     
     
     
203. DEMARQUAY G, Ducros A, Montavont A, Mauguiere F, et al
     Migraine with brainstem aura: Why not a cortical origin?
     Cephalalgia. 2017 Jan 1:333102417738251. doi: 10.1177/0333102417738251.
     PubMed     Text format     Abstract available
     
     
     
204. SUZUKI K, Okuma Y, Uchiyama T, Miyamoto M, et al
     The prevalence, course and clinical correlates of migraine in Parkinson's disease: A multicentre case-controlled study.
     Cephalalgia. 2017 Jan 1:333102417739302. doi: 10.1177/0333102417739302.
     PubMed     Text format     Abstract available
     
     
     
205. KHAN S, Olesen A, Ashina M
     CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data.
     Cephalalgia. 2017 Jan 1:333102417741297. doi: 10.1177/0333102417741297.
     PubMed     Text format     Abstract available
     
     
     
206. MCKENDRICK AM, Chan YM, Vingrys AJ, Turpin A, et al
     Daily vision testing can expose the prodromal phase of migraine.
     Cephalalgia. 2017 Jan 1:333102417741130. doi: 10.1177/0333102417741130.
     PubMed     Text format     Abstract available
     
     
     
207. OKRAGLY AJ, Morin SM, DeRosa D, Martin AP, et al
     Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP).
     Cephalalgia. 2017 Jan 1:333102417740563. doi: 10.1177/0333102417740563.
     PubMed     Text format     Abstract available
     
     
     
208. SCHUBERT V, Auffenberg E, Biskup S, Jurkat-Rott K, et al
     Two novel families with hemiplegic migraine caused by recurrent SCN1A mutation p.F1499L.
     Cephalalgia. 2017 Jan 1:333102417742365. doi: 10.1177/0333102417742365.
     PubMed     Text format     Abstract available
     
     
     
209. CHENG CY, Chen SP, Liao YC, Fuh JL, et al
     Elevated circulating endothelial-specific microRNAs in migraine patients: A pilot study.
     Cephalalgia. 2017 Jan 1:333102417742375. doi: 10.1177/0333102417742375.
     PubMed     Text format     Abstract available
     
     
     
210. NAM JH, Lee HS, Kim J, Kim J, et al
     Salivary glutamate is elevated in individuals with chronic migraine.
     Cephalalgia. 2017 Jan 1:333102417742366. doi: 10.1177/0333102417742366.
     PubMed     Text format     Abstract available
     
     
     
211. AGUILA MR, Rebbeck T, Pope A, Ng K, et al
     Six-month clinical course and factors associated with non-improvement in migraine and non-migraine headaches.
     Cephalalgia. 2017 Jan 1:333102417744360. doi: 10.1177/0333102417744360.
     PubMed     Text format     Abstract available
     
     
     
212. BALESTRI M, Papetti L, Maiorani D, Capuano A, et al
     Features of aura in paediatric migraine diagnosed using the ICHD 3 beta criteria.
     Cephalalgia. 2017 Jan 1:333102417748571. doi: 10.1177/0333102417748571.
     PubMed     Text format     Abstract available
     
     
     
213. FARRIS SG, Thomas JG, Abrantes AM, Lipton RB, et al
     Pain worsening with physical activity during migraine attacks in women with overweight/obesity: A prospective evaluation of frequency, consistency, and correlates.
     Cephalalgia. 2017 Jan 1:333102417747231. doi: 10.1177/0333102417747231.
     PubMed     Text format     Abstract available
     
     
     
214. FARAJDOKHT F, Mohaddes G, Shanehbandi D, Karimi P, et al
     Ghrelin attenuated hyperalgesia induced by chronic nitroglycerin: CGRP and TRPV1 as targets for migraine management.
     Cephalalgia. 2017 Jan 1:333102417748563. doi: 10.1177/0333102417748563.
     PubMed     Text format     Abstract available
     
     
     
215. ANDROULAKIS XM, Rorden C, Peterlin BL, Krebs K, et al
     Modulation of salience network intranetwork resting state functional connectivity in women with chronic migraine.
     Cephalalgia. 2017 Jan 1:333102417748570. doi: 10.1177/0333102417748570.
     PubMed     Text format     Abstract available
     
     
     
216. SIVA ZO, Uluduz D, Keskin FE, Erenler F, et al
     Determinants of glucose metabolism and the role of NPY in the progression of insulin resistance in chronic migraine.
     Cephalalgia. 2017 Jan 1:333102417748928. doi: 10.1177/0333102417748928.
     PubMed     Text format     Abstract available
     
     
     
217. ANTONAZZO IC, Riise T, Cortese M, Berge LI, et al
     Diabetes is associated with decreased migraine risk: A nationwide cohort study.
     Cephalalgia. 2017 Jan 1:333102417748573. doi: 10.1177/0333102417748573.
     PubMed     Text format     Abstract available
     
     
     December 2016
218. ROMOLI M, Costa C, Siliquini S, Corbelli I, et al
     Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events?
     Cephalalgia. 2016 Dec 12. pii: 0333102416683925.
     PubMed     Text format     Abstract available
     
     
     
219. VIANA M, Sances G, Terrazzino S, Sprenger T, et al
     When cervical pain is actually migraine: An observational study in 207 patients.
     Cephalalgia. 2016 Dec 7. pii: 0333102416683917.
     PubMed     Text format     Abstract available
     
     
     November 2016
220. ABUSHIK PA, Bart G, Korhonen P, Leinonen H, et al
     Pro-nociceptive migraine mediator CGRP provides neuroprotection of sensory, cortical and cerebellar neurons via multi-kinase signaling.
     Cephalalgia. 2016 Nov 24. pii: 0333102416681588.
     PubMed     Text format     Abstract available
     
     
     
221. TRIPATHI R, Tselis A, Bernitsas E
     Bilateral cisternal abducens nerve involvement with ophthalmoplegic migraine.
     Cephalalgia. 2016 Nov 23. pii: 0333102416681569.
     PubMed     Text format    
     
     
     
222. AMBROSINI A, Kisialiou A, Schoenen J
     Visual and auditory cortical evoked potentials in interictal episodic migraine: An audit on 624 patients from three centres. Response to the letter by Omland et al.
     Cephalalgia. 2016 Nov 21. pii: 0333102416680616.
     PubMed     Text format    
     
     
     
223. OMLAND PM, Uglem M, Stovner LJ, Sand T, et al
     Re: Visual and auditory cortical evoked potentials in interictal episodic migraine: An audit on 624 patients from three centres.
     Cephalalgia. 2016 Nov 21. pii: 0333102416680613.
     PubMed     Text format    
     
     
     
224. RICE FL, Xie JY, Albrecht PJ, Acker E, et al
     Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine.
     Cephalalgia. 2016 Nov 16. pii: 0333102416677051.
     PubMed     Text format     Abstract available
     
     
     
225. UGLEM M, Omland PM, Nilsen KB, Tronvik E, et al
     Does pain sensitivity change by migraine phase? A blinded longitudinal study.
     Cephalalgia. 2016 Nov 15. pii: 0333102416679955.
     PubMed     Text format     Abstract available
     
     
     
226. LIU HY, Chou KH, Lee PL, Fuh JL, et al
     Hippocampus and amygdala volume in relation to migraine frequency and prognosis.
     Cephalalgia. 2016 Nov 14. pii: 0333102416678624.
     PubMed     Text format     Abstract available
     
     
     
227. GRECO R, Demartini C, Zanaboni AM, Redavide E, et al
     Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms.
     Cephalalgia. 2016 Nov 14. pii: 0333102416678000.
     PubMed     Text format     Abstract available
     
     
     
228. HEPP Z, Dodick DW, Varon SF, Chia J, et al
     Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis.
     Cephalalgia. 2016 Nov 10. pii: 0333102416678382.
     PubMed     Text format     Abstract available
     
     
     
229. HENSEL O
     Comments on "Longitudinal changes in cerebral blood flow velocities in different clinical courses of migraine" by Lee et al.
     Cephalalgia. 2016 Nov 10. pii: 0333102416678001.
     PubMed     Text format    
     
     
     
230. TOYAMA M, Kudo C, Mukai C, Inoue M, et al
     Trigeminal nervous system sensitization by infraorbital nerve injury enhances responses in a migraine model.
     Cephalalgia. 2016 Nov 9. pii: 0333102416678387.
     PubMed     Text format     Abstract available
     
     
     
231. LEBEDEVA ER, Kobzeva NR, Gilev DV, Kislyak NV, et al
     Psychosocial factors associated with migraine and tension-type headache in medical students.
     Cephalalgia. 2016 Nov 8. pii: 0333102416678389.
     PubMed     Text format     Abstract available
     
     
     
232. MALEKI N, Kurth T, Field AE
     Age at menarche and risk of developing migraine or non-migraine headaches by young adulthood: A prospective cohort study.
     Cephalalgia. 2016 Nov 8. pii: 0333102416677999.
     PubMed     Text format     Abstract available
     
     
     
233. ZHANG Y, Chen N, Zhou M, Guo J, et al
     A novel SCN1A mutation identified in a Chinese family with familial hemiplegic migraine: A case report.
     Cephalalgia. 2016 Nov 8. pii: 0333102416677049.
     PubMed     Text format     Abstract available
     
     
     
234. LISICKI M, Ruiz-Romagnoli E, D'Ostilio K, Piedrabuena R, et al
     Familial history of migraine influences habituation of visual evoked potentials.
     Cephalalgia. 2016 Nov 7. pii: 0333102416673207.
     PubMed     Text format     Abstract available
     
     
     
235. JUAN Y, Shu O, Jinhe L, Na Y, et al
     Migraine prevention with percutaneous mastoid electrical stimulator: A randomized double-blind controlled trial.
     Cephalalgia. 2016 Nov 7. pii: 0333102416678623.
     PubMed     Text format     Abstract available
     
     
     
236. VURALLI D, Boran HE, Cengiz B, Coskun O, et al
     Somatosensory temporal discrimation remains intact in tension-type headache whereas it is disrupted in migraine attacks.
     Cephalalgia. 2016 Nov 4. pii: 0333102416677050.
     PubMed     Text format     Abstract available
     
     
     October 2016
237. KALITA J, Bhoi SK, Misra UK
     Effect of high rate rTMS on somatosensory evoked potential in migraine.
     Cephalalgia. 2016 Oct 25. pii: 0333102416675619.
     PubMed     Text format     Abstract available
     
     
     
238. STREEL S, Donneau AF, Dardenne N, Hoge A, et al
     Screening for the metabolic syndrome in subjects with migraine.
     Cephalalgia. 2016 Oct 4. pii: 0333102416672494.
     PubMed     Text format     Abstract available
     
     
     September 2016
239. IBRAHIMI K, Vermeersch S, Frederiks P, Geldhof V, et al
     The influence of migraine and female hormones on capsaicin-induced dermal blood flow.
     Cephalalgia. 2016 Sep 28. pii: 0333102416668659.
     PubMed     Text format     Abstract available
     
     
     
240. SAMANCI B, Coban O, Baykan B
     Late onset aura may herald cerebral amyloid angiopathy: A case report.
     Cephalalgia. 2016;36:998-1001.
     PubMed     Text format     Abstract available
     
     
     
241. KAUFMANN D, Bates EA, Yagen B, Bialer M, et al
     sec-Butylpropylacetamide (SPD) has antimigraine properties.
     Cephalalgia. 2016;36:924-35.
     PubMed     Text format     Abstract available
     
     
     August 2016
242. ZHANG X, Strassman AM, Novack V, Brin MF, et al
     Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
     Cephalalgia. 2016;36:875-86.
     PubMed     Text format     Abstract available
     
     
     
243. NAGY-GROCZ G, Tar L, Bohar Z, Fejes-Szabo A, et al
     The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat.
     Cephalalgia. 2016;36:849-61.
     PubMed     Text format     Abstract available
     
     
     
244. RAUSCHEL V, Ruscheweyh R, Krafczyk S, Straube A, et al
     Test-retest reliability of visual-evoked potential habituation.
     Cephalalgia. 2016;36:831-9.
     PubMed     Text format     Abstract available
     
     
     May 2016
245. RAUCCI U, Vanacore N, Paolino MC, Silenzi R, et al
     Vertigo/dizziness in pediatric emergency department: Five years' experience.
     Cephalalgia. 2016;36:593-8.
     PubMed     Text format     Abstract available
     
     
     February 2016
246. BURGOS-VEGA CC, Ahn DD, Bischoff C, Wang W, et al
     Meningeal transient receptor potential channel M8 activation causes cutaneous facial and hindpaw allodynia in a preclinical rodent model of headache.
     Cephalalgia. 2016;36:185-93.
     PubMed     Text format     Abstract available
     
     
     January 2016
247. MAY A
     Letter from the Editor-in-Chief.
     Cephalalgia. 2016;36:3-4.
     PubMed     Text format    
     
     
     
248. ABU BAKAR N, Tanprawate S, Lambru G, Torkamani M, et al
     Quality of life in primary headache disorders: A review.
     Cephalalgia. 2016;36:67-91.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: